P
Posco DX Co Ltd
KRX:022100
Posco DX Co Ltd
KRX:022100
Price:
19 950
KRW
2.26%
Market Cap:
3T
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Posco DX Co Ltd
19950
+440 (+2.26%)
| 52 Week Range |
19 510
74 200
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Posco DX Co Ltd
Balance Sheet
Balance Sheet Decomposition
Posco DX Co Ltd
Posco DX Co Ltd
| Current Assets | 597.3B |
| Cash & Short-Term Investments | 121.7B |
| Receivables | 413.1B |
| Other Current Assets | 62.4B |
| Non-Current Assets | 218.3B |
| Long-Term Investments | 22.8B |
| PP&E | 121.8B |
| Intangibles | 12B |
| Other Non-Current Assets | 61.6B |
| Current Liabilities | 300.5B |
| Accounts Payable | 110.5B |
| Accrued Liabilities | 16.2B |
| Other Current Liabilities | 173.7B |
| Non-Current Liabilities | 10.2B |
| Long-Term Debt | 2.3B |
| Other Non-Current Liabilities | 7.8B |
Balance Sheet
Posco DX Co Ltd
Posco DX Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
16 578
|
18 395
|
79 904
|
71 216
|
59 284
|
51 004
|
97 736
|
137 287
|
29 621
|
32 015
|
|
| Cash |
2
|
6
|
3
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
16 576
|
18 389
|
79 901
|
71 216
|
59 281
|
51 001
|
97 736
|
137 287
|
29 621
|
32 015
|
|
| Short-Term Investments |
61 382
|
55 912
|
1 488
|
485
|
4 205
|
327
|
10 341
|
24 255
|
30 877
|
30 224
|
|
| Total Receivables |
296 736
|
324 344
|
285 857
|
284 247
|
286 885
|
272 474
|
318 202
|
256 539
|
341 585
|
440 950
|
|
| Accounts Receivables |
280 980
|
308 526
|
270 497
|
277 076
|
277 877
|
265 280
|
306 578
|
239 542
|
285 007
|
400 776
|
|
| Other Receivables |
15 756
|
15 818
|
15 360
|
7 171
|
9 008
|
7 194
|
11 624
|
16 997
|
56 578
|
40 174
|
|
| Inventory |
22 680
|
14 689
|
6 671
|
3 413
|
1 085
|
1 387
|
2 066
|
5 540
|
3 496
|
32 220
|
|
| Other Current Assets |
24 838
|
15 556
|
13 424
|
37 957
|
28 019
|
17 023
|
25 485
|
56 145
|
36 231
|
68 084
|
|
| Total Current Assets |
422 214
|
428 896
|
387 343
|
397 319
|
379 478
|
342 215
|
453 829
|
479 766
|
441 811
|
603 492
|
|
| PP&E Net |
189 414
|
172 416
|
159 406
|
150 616
|
152 814
|
146 336
|
118 946
|
112 881
|
109 296
|
107 849
|
|
| PP&E Gross |
189 414
|
172 416
|
159 406
|
150 616
|
152 814
|
146 336
|
118 946
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
88 949
|
113 779
|
119 493
|
137 220
|
147 625
|
154 448
|
97 267
|
0
|
0
|
0
|
|
| Intangible Assets |
63 701
|
51 722
|
32 514
|
25 690
|
23 690
|
23 646
|
9 518
|
7 003
|
7 703
|
11 720
|
|
| Goodwill |
77 298
|
77 298
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
8 912
|
7 529
|
10 348
|
9 261
|
6 603
|
5 396
|
20 389
|
12 629
|
11 301
|
16 138
|
|
| Long-Term Investments |
43 875
|
49 713
|
43 046
|
35 202
|
33 307
|
32 173
|
23 261
|
25 774
|
31 428
|
25 222
|
|
| Other Long-Term Assets |
37 215
|
36 847
|
61 284
|
44 112
|
50 409
|
60 466
|
49 476
|
46 393
|
45 432
|
87 174
|
|
| Other Assets |
77 298
|
77 298
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
842 630
N/A
|
824 421
-2%
|
693 941
-16%
|
662 200
-5%
|
646 301
-2%
|
610 232
-6%
|
675 419
+11%
|
684 445
+1%
|
646 970
-5%
|
851 594
+32%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
109 482
|
74 597
|
74 955
|
79 075
|
57 216
|
71 616
|
104 398
|
72 927
|
99 181
|
132 922
|
|
| Accrued Liabilities |
3 995
|
4 243
|
6 196
|
2 293
|
3 607
|
9 690
|
15 021
|
15 263
|
13 659
|
23 343
|
|
| Short-Term Debt |
64 077
|
91 210
|
704
|
2 172
|
1 678
|
1 668
|
1 386
|
983
|
711
|
382
|
|
| Current Portion of Long-Term Debt |
33 979
|
5 243
|
0
|
0
|
0
|
0
|
1 153
|
556
|
639
|
1 008
|
|
| Other Current Liabilities |
173 417
|
162 329
|
212 986
|
177 070
|
150 309
|
135 425
|
146 577
|
198 749
|
161 553
|
273 477
|
|
| Total Current Liabilities |
384 950
|
337 621
|
294 841
|
260 611
|
212 810
|
218 400
|
268 536
|
288 478
|
275 743
|
431 132
|
|
| Long-Term Debt |
38 398
|
43 164
|
1 835
|
77
|
77
|
77
|
897
|
521
|
653
|
1 154
|
|
| Minority Interest |
2 622
|
914
|
3 848
|
584
|
561
|
570
|
1 089
|
1 299
|
1 658
|
1 822
|
|
| Other Liabilities |
50 639
|
55 629
|
65 809
|
26 697
|
33 179
|
52 563
|
39 716
|
25 483
|
11 370
|
5 316
|
|
| Total Liabilities |
476 609
N/A
|
437 328
-8%
|
358 638
-18%
|
287 968
-20%
|
246 626
-14%
|
271 609
+10%
|
310 239
+14%
|
315 780
+2%
|
289 424
-8%
|
439 424
+52%
|
|
| Equity | |||||||||||
| Common Stock |
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
76 017
|
|
| Retained Earnings |
67 781
|
86 348
|
35 082
|
75 106
|
100 625
|
41 567
|
68 713
|
71 702
|
58 981
|
114 937
|
|
| Additional Paid In Capital |
224 419
|
224 410
|
224 410
|
224 403
|
224 406
|
224 403
|
224 403
|
224 403
|
224 403
|
224 403
|
|
| Unrealized Security Profit/Loss |
5
|
1 108
|
320
|
442
|
606
|
3 011
|
3 789
|
4 941
|
3 808
|
4 143
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 097
|
0
|
0
|
|
| Other Equity |
2 202
|
790
|
115
|
853
|
768
|
353
|
164
|
2 578
|
1 952
|
956
|
|
| Total Equity |
366 021
N/A
|
387 093
+6%
|
335 304
-13%
|
374 232
+12%
|
399 675
+7%
|
338 623
-15%
|
365 180
+8%
|
368 664
+1%
|
357 546
-3%
|
412 170
+15%
|
|
| Total Liabilities & Equity |
842 630
N/A
|
824 421
-2%
|
693 941
-16%
|
662 200
-5%
|
646 301
-2%
|
610 232
-6%
|
675 419
+11%
|
684 445
+1%
|
646 970
-5%
|
851 594
+32%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
152
|
152
|
152
|
152
|
152
|
152
|
152
|
152
|
152
|
152
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
